Chronic urticaria

Urticaria and Angioedema

Volumn , Issue , 2010, Pages 45-56

  Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892302552     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-79048-8_6     Document Type: Chapter

References (42)

1. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schäfer T, Simon D, Vena GA, Wedi B. EAACI/GA (2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64:1427-43
2. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol. 1981;104:369-81
3. Maurer M, Ortonne J-P, Zuberbier T. Chronic urticaria: an internet survey on health behaviors, symptom patterns, and treatment needs in european adult patients. Br J Dermatol. 2009;160:633-41
4. Iffländer J, editor. Akute Urtikaria - Ursachen, Verlauf und Therapie. Dissertation (Med. Doct.). Berlin: Humboldt University; 1999
5. Zuberbier T, Münzberger CH, Haustein U, Trippas E, Mariz SD, Czarnetzki BM. Double-blind crossover study of high dose cetirizine in cholinergic urticaria. Dermatology 1996;193:324-7
6. Zuberbier T, Iffländer J, Semmler C, Czarnetzki BM. Acute urticaria - clinical aspects and therapeutic responsiveness. Acta Derm Venereol. 1996;76:295-7
7. Haas N, Birkle-Berlinger W, Henz BM. Prognosis of acute urticaria in children. Acta Derm Venereol. 2005;85:74-5
8. Zuberbier T. Urticaria. Allergy 2003;58:1224-34
9. Paul E, Greilich KD. Zur Epidemiologie der Urtikariaerkrankungen. Hautarzt 1991;42:366-75
10. Gaig P, Olona M, Munoz Lejarazu D, Caballero MT, Dominguez FJ, Echechipia S, Garcia Abujeta JL, Gonzalo MA, Lleonart R, Martinez Cocera C, Rodriguez A, Ferrer M. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol. 2004;14:214-20
11. Ogunbiyi AO, Owoaje E, Ndahi A. Prevalence of skin disorders in school children in Ibadan, Nigeria. Pediatr Dermatol. 2005;22:6-10
12. Vazquez Nava F, Almeida Arvizu VM, Sanchez Nuncio HR, Villanueva Carreto Mde L, Guidos Fogelbach GA. Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico. Rev Alerg Mex. 2004;51:181-8
13. Maurer M. Allergie vom Soforttyp (Typ I) - Mastzellen und Frühphasenreaktion. In: Saloga J, Klimek L, Buhl R, Mann W, Knop J, editors. Allergologie-Handbuch Grundlagen und klinische Praxis. Stuttgart: Schattauer; 2006. p. 70-81
14. Metz M, Bergmann P, Zuberbier T, Maurer M. Successful treatment of cholinergic urticaria with anti-IgE therapie. Allergy 2008;63:143-250
15. Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008;213:251-60
16. Maurer M, Metz M, Magerl M, Siebenhaar F, Staubach P. Autoreactive urticaria and autoimmune urticaria. Hautarzt 2004;55:350-6
17. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeir P. EAACI/GA2LEN task force consensus report: the autologous serum skin test in Urticaria. Allergy 2009;64:1256-68
18. Metz M, Giménez-Arnau A, Borzova E, Grattan CE, Magerl M, Maurer M. Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol 2009;123:705-6
19. Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, Opper B, Magerl M, Lüdtke R, Kromminga A, Maurer M. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006;212:150-9
20. Cribier B. Urticaria and hepatitis. Clin Rev Allergy Immunol. 2006;30:25-9
21. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. 2003;49:861-4
22. Barahona RL, Maguina VC, Naquira VC, et al. Human blastocystosis: prospective study symptomatology and associated epidemiological factors. Rev Gastroenterol Peru. 2003;23:29-35
23. Champion RH, Roberts S O B, Carpenter RG, Roger JH. Urticaria and angio-edema: a review of 554 patients. Br J Dermatol. 1969;81:588-97
24. Ergon MC, Iåknur T, Yuæesoy M, Oǧkan S. Candida spp. colonization and serum anticandidal antibody levels in patients with chronic urticaria. Clin Exp Dermatol. 2007;32:740-3
25. Maurer M, Metz M, Magerl M, Siebenhaar F, Staubach P. Relevance of food allergies and intolerance reactions as causes of urticaria. Hautarzt 2003;54:138-43
26. Buhner S, Reese I, Kuehl F, Lochs H, Zuberbier T. Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy 2004;59:1118-23
27. Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008;63:777-80
28. Bajaj AK, Saraswat A, Upadhyay A, Damisetty R, Dhar S. Autologous serum therapy in chronic urticaria: old wine in a new bottle. Indian J Dermatol Venereol Leprol. 2008;74:109-13
29. Liu C, Zhou J, Zhang LD, Wang YX, Kang ZM, Chen YZ, Jiang CL. Rapid inhibitory effect of corticosterone on histamine release from rat peritoneal mast cells. Horm Metab Res. 2007;39(4):273-7
30. Harrison CA, Bastan R, Peirce MJ, Munday MR, Peachell PT. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506. Br J Pharmacol. 2007;150(4):509-18
31. Stellato C, De Paulis A, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol. 1992;98:800-4
32. Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, Kobza Black A, Greaves MW. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol. 2000;143(2):365-72
33. Kolde G, Frosch PJ, Czarnetzki BM. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol. 1984;83:175-8
34. Yen A, Gigli I, Barrett KE. Modulation of human cutaneous mast cell responsiveness by a single, low-dose, PUVA treatment. J Allergy Clin Immunol. 1991;88:395-401
35. Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol. 1985;65:449-50
36. Olafsson JH, Larko O, Roupe G, Granerus G, Bengtsson U. Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study. Acta Dermatol Res. 1986;278:228-31
37. Thormann J, Laurberg G, Zachariae H. Oral sodium cromoglycate in chronic urticaria. Allergy 1980;35:139-41
38. Grattan C E H, Francis DM, Slater N G P, Barlow RJ, Greaves MW. Plasmapheresis for severe unremitting chronic urticaria. Lancet 1992;339:1078-80
39. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664-672
40. O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, Barlow RJ, Winkelmann RK, Greaves MW. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998;138:101-6
41. Lippert U, Möller A, Welker P, Artuc M, Grützkau A, Henz BM. Inhibition of cytokine secretion from human mast cells and basophils by H1-and H2-receptor antagonists. Exp Dermatol. 2000;9:118-24
42. Siebenhaar F, Degener F, Zuberbier T, Martus M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allegy Clin Immynol 2009;123:672-9